Medicine and Dentistry
Abdominal Pain
33%
Acute Kidney Injury
40%
Adverse Event
25%
Anemia
12%
Art Therapy
20%
Biochemical Recurrence
12%
Biological Marker
12%
Blood Transfusion
40%
Bone Lesion
12%
Bortezomib
37%
Brachyspira
50%
Cancer Research
12%
Cancer Therapy
12%
Cardiovascular System
25%
Carfilzomib
12%
Case Fatality Rate
20%
Chi Square Test
20%
Colectomy
33%
Colonoscopy
33%
Coloproctology
25%
COVID-19 Vaccination
100%
Cross Sectional Study
100%
Daratumumab
12%
Diagnostic Test
10%
Diseases
25%
Extramammary Paget's Disease
100%
Histopathology
33%
Immunoglobulin
12%
Immunoglobulin A
12%
Immunomodulatory Drug
20%
Intestinal Wall
50%
Kaplan Meier Method
12%
Lenalidomide
50%
M Protein
25%
Metastatic Carcinoma
66%
Multiple Myeloma
100%
Neoplasm
33%
Neutropenia
12%
Observational Study
100%
Odds Ratio
100%
Open Surgery
25%
Oral Cancer
100%
Outpatient
33%
Overall Survival
37%
Patient with Type 2 Diabetes
50%
Population Research
12%
Portal Vein Thrombosis
100%
Postoperative Complication
20%
Prevalence
25%
Progression Free Survival
37%
Proteasome Inhibitor
12%
Rectal Bleeding
66%
Rectum Anterior Resection
25%
Rectum Cancer
100%
Retrospective Cohort Study
100%
Retrospective Study
12%
Spirochete Infection
100%
Surgery
33%
Surgical Infection
40%
Surgical Mortality
20%
Survival Time
12%
Symptomatic Treatment
12%
Synovial Sarcoma
100%
Telemedicine
33%
Thoracic Wall
100%
Time to Treatment
12%
Transverse Colon
100%
Treatment Withdrawal
12%
Urinary Tract Infection
40%
Youden Index
10%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
25%
Anemia
12%
Biochemical Recurrence
12%
Biological Marker
12%
Bone Lesion
12%
Bortezomib
37%
Carfilzomib
12%
Case Fatality Rate
16%
Daratumumab
12%
Glycosylated Hemoglobin
16%
Immunoglobulin
12%
Immunoglobulin A
12%
Lenalidomide
50%
M Protein
25%
Malignant Neoplasm
25%
Multiple Myeloma
100%
Neutropenia
12%
Observational Study
100%
Overall Survival
37%
Population Study
12%
Progression Free Survival
37%
Proteasome Inhibitor
12%
Retrospective Study
12%
Survival Time
12%
Vaccination Policy
100%